Injection Pen Market

The report "Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, obesity, fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030", is projected to reach USD 74.1 billion by 2030 from USD 47.0 billion in 2024, at a CAGR of 7.9% during the forecast period.

Browse 213 market data Tables and 62 Figures spread through 242 Pages and in-depth TOC on "Injection Pen Market by Type (Disposable and Reusable Pens), Therapy (Diabetes Therapy (Insulin, GLP-1), Growth Hormone Therapy, Osteoporosis, obesity, fertility), End User (Homecare and Hospitals & Clinics), and Region - Global Forecast to 2030"
View detailed Table of Content here - https://www.marketsandmarkets.com/Market-Reports/injection-pen-market-42342539.html

Globally, the growing burden of chronic diseases like diabetes, obesity, rising aging population  globally are anticipated to accelerate the demand for injection pen, further propelling the adoption of injection pen products . Moreover, the growing focus on patient centric design and government initiative to aid affordibility and accessibility are likely to fuel the market growth. Moreover, the increasing investments for new product development and growing  adoption of home care settings and self administration owing to its advantages are expecetd to support  the injection pen market growth during the forecast period.

Risk of injection site reactions, and lack of training and education among patients associated are likely to hamper the growth of injection pen market

The disposable injection pen segment, is expected to register the largest market share of the global injection pen market  in 2023.

The injection pen market is segmented based on type. Based on type, this is segmented into disposable and reusable injection pens. The disposable injection pens segment held the largest share in the injection pen market. The growth is attributed to ease of use, lack of risk of needle stick infections and the presence of a built-in cartridge to reduce the need for manually loading the cartridge, offering convenience for patients with reduced dexterity or visual detriments have supported the higher adoption of disposable injection pens among patients. These factors are boosting the growth of disposable injection pens at higher pace.

The home care settings is anticipated to grow at a significant rate and capture the largest share in injection pen market in 2023.

The injection pen market is segmented into home care settings and hospitals & clinics based on end user. In 2023, the home care settings segment led the injection pen market, capturing the largest share and growing at a faster pace. This growth can be attributed to several factors: the rising prevalence of chronic diseases, an aging population, the convenience of self-administration, advancements in technology, and favourable reimbursement options. All these factors are driving the increasing use of injection pens in home care settings.

“The North America market, by region, to register highest growth rate in the forecast period.”

On the basis of region, the injection pen market is segmented into North America, Europe, Asia Pacific, and the Latin America, Middle East & Africa.  The North America market is likely to witness significant market growth. This is attribute to the rise in geriatric patient population, increasing cases of chronic diseases, moreover improving healthcare infrastructure and the implementation of supportive government initiatives to increase the accessibility injection pen products. The geographical expanion and presence of key players in the region are likely to support  growth of injection market in North America.

As of 2023, injection pen market was dominated by Novo Nordisk A/S (Denmark), Eli Lilly and Company (US), Sanofi (France), Ypsomed Holding AG (Switzerland), Becton, Dickinson and Company (US), Merck KGaA (Germany), AstraZeneca (UK), Owen Mumford (UK) among others.

Don’t miss out on business opportunities in Injection Pen Market. Speak to our analyst and gain crucial industry insights that will help your business grow.

About MarketsandMarkets™

MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.

Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.

MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.

Contact:
Mr. Rohan Salgarkar
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]